Vitronectin in atherosclerotic disease


Ekmekci O. , Ekmekci H.

CLINICA CHIMICA ACTA, cilt.368, ss.77-83, 2006 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 368
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1016/j.cca.2005.12.015
  • Dergi Adı: CLINICA CHIMICA ACTA
  • Sayfa Sayıları: ss.77-83

Özet

Atherosclerosis is characterized by the development of an intimal thickening that contains monocytes, T lymphocytes, and smooth muscle cells within an accumulation of lipid and extracellular matrix proteins. Vitronectin is a plasma glycoprotein implicated as a regulator of diverse physiological process, including blood coagulation, fibrinolysis, pericellular proteolysis, complement dependent immune responses, and cell attachment and spreading. Because of its ability to bind platelet glycoproteins and mediate platelet adhesion and aggregation at sites of vascular injury, vitronectin has become an important mediator in the pathogenesis of coronary atherosclerosis. (c) 2005 Elsevier B.V. All rights reserved.